Maria A. Fedorova

Maria A. Fedorova

Auto-generated profile, based on publicly available information

Maria A. Fedorova

Almazov National Medical Research Center

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2022 in South Russian Journal of Therapeutic Practice
Verified
Journal Article
Open access
PDF file
PFPetr Fedotov
Petr Fedotov
MSMaria Simonenko
Maria Simonenko
JSJ. V. Sazonova
J. V. Sazonova
MBM. A. Bortsova
M. A. Bortsova
AKA. N. Kostomarov
A. N. Kostomarov
MSM. Y. Sitnikova
M. Y. Sitnikova
Objective: to estimate the survival of patients in the heart transplantation waiting list (HTx WL) at Almazov National Medical Research Centre (V.A. Almazov NMRC), Saint-Petersburg, Russia, from 2010 to 2018 and to define factors for death among these patients.Materials and methods: it was a single-centre retrospective study involving 151 patients with end-stage chronic heart failure (CHF) classes III-IV (NYHA) in the HTx WL.Results: the dynamic of decreasing mortality was revealed. Based on the results of constructing the discriminant function, four factors predicting the survival of patients in the HTx WL, namely, ACE inhibitors/ARBs, beta-blockers, status 1 of UNOS, CHF NYHA class IV, were pointed out. The model has sufficient resolving power but is not capable of predicting the outcome in the presence of acute decompensation of CHF.Conclusion: mortality in the HTx WL for the period 2010-2018 decreased that was associated with an active implementation of cardiac surgical methods as a «bridge» to transplant and optimal medical therapy, including ACE inhibitors/ARBs and beta-blockers in patients supported with inotropes (UNOS 1B). The greatest risk of mortality was found in CHF class IV and status 1 by UNOS.

5 December 2023 in Kardiologiia
Verified
Journal Article
Open access
PDF file
MBM. A. Bortsova
M. A. Bortsova
EDElena Demchenko
Elena Demchenko
PFPetr Fedotov
Petr Fedotov
OGO. S. Ganenko
O. S. Ganenko
MOM. A. Osipova
M. A. Osipova
MSM. Yu. Sitnikova
M. Yu. Sitnikova
Aim To assess the tolerability of an individualized physical rehabilitation program (PRP) in inotrope-dependent patients with end-stage chronic heart failure (CHF). Material and methods This prospective randomized study included 120 men aged 18-65 years with left ventricular ejection fraction ≤30 % and blood pressure ≥90 / 60 mm Hg. Patients who have received dobutamine or dopamine for ≥2 weeks were randomized into two groups: group 1, 40 patients who participated in the PRP and group 2, 40 patients who did not participate in the PRP. Group 3 included 40 patients without inotropic support who participated in the PRP. Results Patients of groups 1 and 3 attended >80 % of the scheduled classes without developing life-threatening adverse events (AEs) associated with exercise (E). After 6 months of the study, the exercising patients achieved a comparable (average) E intensity: 44 [35; 50]% and 45 [40;52]% of heart rate reserve and Borg scale scores 14 [12; 14] and 13 [11; 14] in groups 1 and 3, respectively (p>0.05). Initially, after 3 and 6 months at the peak of physical activity in groups 1 and 3, there was no decrease in arterial blood oxygen saturation according to pulse oximetry (SpO 2 ) <93 %. At baseline, lactate levels in central venous blood at rest were normal in all groups. After 6 months, the lactate concentration was 1.1 mmol / l in group 1, 2.3 mmol / l in group 2, and 1.4 mmol / l in group 3 (р1-2=0.005; p2-3=0.008, respectively). At the E peak at baseline, after 3 and 6 months, comparable increases in lactate not exceeding 3 mmol / l were detected in groups 1 and 3. Conclusion The study allowed assessment of the tolerability of individualized PRP performed at the aerobic level of energy supply, in inotropic-dependent patients with CHF. Individualized 6-month PRP in inotropic-dependent patients with end-stage CHF, provided safety criteria are met, is well tolerated and does not increase the number of AEs associated with CHF and physical rehabilitation (PR). Continued inotropic support with dopamine or dobutamine should not be considered as a contraindication to PR in patients with CHF in the absence of E intolerance or life-threatening AEs.

14 December 2020 in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
Verified
Journal Article
Open access
PDF file
MBM. A. Bortsova
M. A. Bortsova
EDE. A. Demchenko
E. A. Demchenko
ABAndrei Evgen'evich Bautin
Andrei Evgen'evich Bautin
PFPetr Fedotov
Petr Fedotov
OGO. S. Ganenko
O. S. Ganenko
MSM. Yu. Sitnikova
M. Yu. Sitnikova
Влияние физических тренировок на функциональные и гемодинамические показатели пациентов с хронической сердечной недостаточностью III–IV функционального класса в зависимости от потребности в инотропной поддержке

6 May 2025 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
LKLubov Korneva
Lubov Korneva
MOM. A. Osipova
M. A. Osipova
MBM. A. Bortsova
M. A. Bortsova
DKD. A. Kilina
D. A. Kilina
AKAnna Kostareva
Anna Kostareva
PFPetr Fedotov
Petr Fedotov
One of the urgent tasks is the search for early and specific markers of cardio­vascular diseases (CVD) in order to stratify the cardiovascular risk, develop methods for their prevention, early diagnosis and treatment. In recent decades, considerable attention has been paid to plasma cell-free nucleic acids free: circulating cell-free DNA (сfDNA) and circulating non-coding RNA, in particular microRNA, which are considered as promising prognostic and diagnostic bio­markers of many pathological conditions, since they play a key role in the regu­lation of physiological and pathophysiological processes. This review covers current understanding of the potential of plasma cfDNA and microRNA assessment in cardiovascular patients as specific biomarkers for diagnosis, risk stratification, severity assessment and monitoring of CVD, with a focus on coronary artery dise­ase, heart failure and cardiac allograft rejection, where this area of research is promising.

28 October 2021 in Cardiosomatics
Verified
Journal Article
Open access
PDF file
MBMaria A. Bortsova
Maria A. Bortsova
EDElena Demchenko
Elena Demchenko
ABAndrei Evgen'evich Bautin
Andrei Evgen'evich Bautin
PFPetr Fedotov
Petr Fedotov
AMAleksandr Marichev
Aleksandr Marichev
БАБорцова Мария Александровна
Борцова Мария Александровна
Aim. To assess the effect of physical rehabilitation on dynamics of oxygen and lactate status indicators in inotrope-dependent patients with stable chronic heart failure (CHF) of IIIIV functional class (FC). Material and methods. A randomized prospective study included 120 men, aged 1865, hospitalized at Almazov National Medical Research Centre due to CHF IIIIV FC, left ventricular ejection fraction (LVEF) 30%; with blood pressure (BP)90/60 mm Hg. Patients who received dobutamine or dopamine for 2 weeks were randomized into 3 groups: 1st participating in the program of physical training (PPT), 2nd not participating; 3rd group patients without inotropic support participating in PPT. Results. Oxygen extraction ratio (O2ER) at rest was increased, while central venous oxygen saturation (ScvO2) was decreased in all groups at baseline, after 3 and 6 months. Initially, at rest, central venous blood lactate (lactate) was normal in all groups. By the 6th month, lactate in group 2 became higher than in group 1 (p=0.005) and group 3 (p=0.008). Initially, after 3 and 6 months, at peak of exercise in groups 1 and 3, lactate and O2ER increased, and ScvO2 decreased without development of life-threatening adverse events. By the 6th month, in groups 1 and 3, the distance of 6-minute walk test increased: p=0.004 and p0.00001 and the strength of hand muscles increased: p=0.01 and p=0.005. Conclusion. In patients with CHF IIIIV FC at rest, regardless of participation in PPT and inotropic therapy, there were comparable disturbances of oxygen status, characterized by decreased level of ScvO2 and increased level of O2ER, in the absence of decrease in arterial blood saturation. At peak of aerobic exercise of mild and moderate intensity in patients with advanced CHF, regardless of inotropic support, there was a comparable increase in the level of lactate and O2ER, as well as a decrease in ScvO2, which was not accompanied by life-threatening adverse events. The participation of inotrope-dependent patients in PPT is associated with decrease in blood lactate at rest, which, along with increase in hand muscle strength and exercise tolerance, may indicate an improvement in condition of muscle tissue.